Comparison of Electroacupuncture and Moxibustion for Relieving Visceral Hypersensitivity in Rats with Constipation-Predominant Irritable Bowel Syndrome

Comparison of Electroacupuncture and Moxibustion for Relieving Visceral Hypersensitivity in Rats with Constipation-Predominant Irritable Bowel Syndrome

Aim. To compare whether there is different effect between electroacupuncture (EA) and moxibustion (Mox) on visceral hypersensitivity (their analgesic effects) in constipation-predominant irritable bowel syndrome (C-IBS). Methods. EA at 1 mA and 3 mA and Mox at 43°C and 46°C were applied to the Shan...

Full description

Bibliographic Details
Main Authors:	Zhao, Ji-Meng, Chen, Liu, Zhou, Ci-Li, Shi, Yin, Li, Yu-Wei, Shang, Hai-Xia, Wu, Lu-Yi, Bao, Chun-Hui, Dou, Chuan-Zi, Wu, Huan-Gan
Format:	Online
Language:	English
Published:	Hindawi Publishing Corporation 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055954/

Similar Items

Constipation-Predominant Irritable Bowel Syndrome Associated to Hyperprolactinemia
by: Seretis, C., et al.
Published: (2011)

Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation
by: Eswaran, Shanti, et al.
Published: (2014)

Warming Moxibustion Relieves Chronic Visceral Hyperalgesia in Rats: Relations to Spinal Dynorphin and Orphanin-FQ System
by: Qi, Li, et al.
Published: (2013)

Electroacupuncture versus Moxibustion for Irritable Bowel Syndrome: A Randomized, Parallel-Controlled Trial
by: Shi, Yin, et al.
Published: (2015)

Mechanisms Underlying the Analgesic Effect of Moxibustion on Visceral Pain in Irritable Bowel Syndrome: A Review
by: Huang, Renjia, et al.
Published: (2014)

Moxibustion treatment for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial
by: Bao, Chunhui, et al.
Published: (2016)

Autonomic nervous system activity in constipation-predominant irritable bowel syndrome patients
by: Mazur, Marcel, et al.
Published: (2012)

Functional Constipation and Constipation-Predominant Irritable Bowel Syndrome in the General Population: Data from the GECCO Study
by: Enck, Paul, et al.
Published: (2016)

Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases
by: Ceuleers, Hannah, et al.
Published: (2016)

Acupuncture and moxibustion for visceral pain
Published: (2012)

Randomized Clinical Trial: The Clinical Effects of Herb-Partitioned Moxibustion in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome
by: Ma, Yu-xia, et al.
Published: (2013)

Moxibustion for Diarrhea-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Tang, Bozong, et al.
Published: (2016)

Case of Extraordinary Constipation of the Bowels Relieved by Medicine
Published: (1830)

Main ion channels and receptors associated with visceral hypersensitivity in irritable bowel syndrome
by: de Carvalho Rocha, Heraldo Arcela, et al.
Published: (2014)

The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments
by: Farzaei, Mohammad H, et al.
Published: (2016)

New Pathways, New Targets: Visceral Hypersensitivity Pathogenesis in Irritable Bowel Syndrome
by: Barshop, Kenneth, et al.
Published: (2016)

Electroacupuncture for patients with diarrhea-predominant irritable bowel syndrome or functional diarrhea: A randomized controlled trial
by: Zheng, Hui, et al.
Published: (2016)

Study on the Mechanism Underlying the Regulation of the NMDA Receptor Pathway in Spinal Dorsal Horns of Visceral Hypersensitivity Rats by Moxibustion
by: Wang, L. D., et al.
Published: (2016)

The Spectrum of Constipation-Predominant Irritable Bowel Syndrome and Chronic Idiopathic Constipation: US Survey Assessing Symptoms, Care Seeking, and Disease Burden
by: Heidelbaugh, Joel J, et al.
Published: (2015)

Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy, and the United Kingdom
by: DiBonaventura, Marco daCosta, et al.
Published: (2012)

The human intestinal microbiota of constipated-predominant irritable bowel syndrome patients exhibits anti-inflammatory properties
by: Gobert, Alain P., et al.
Published: (2016)

Irritable Bowel Syndrome, Particularly the Constipation-Predominant Form, Involves an Increase in Methanobrevibacter smithii, Which Is Associated with Higher Methane Production
by: Ghoshal, Ujjala, et al.
Published: (2016)

Moxibustion in the management of irritable bowel syndrome: systematic review and meta-analysis
by: Park, Jae-Woo, et al.
Published: (2013)

Optimal management of constipation associated with irritable bowel syndrome
by: Furnari, Manuele, et al.
Published: (2015)

Suspended moxibustion at Tianshu (ST25) inhibits prokineticin 1 and prokineticin receptor 1 expression in the spinal cord of rats with chronic visceral hypersensitivity☆
by: Zhao, Chen, et al.
Published: (2012)

Brain regions involved in moxibustion-induced analgesia in irritable bowel syndrome with diarrhea: a functional magnetic resonance imaging study
by: Zhu, Yi, et al.
Published: (2014)

Targeted therapies for diarrhea-predominant irritable bowel syndrome
by: Olden, Kevin W
Published: (2012)

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
by: Lacy, Brian E
Published: (2016)

Electroacupuncture at He-Mu points reduces P2X4 receptor expression in visceral hypersensitivity
by: Guo, Xinxin, et al.
Published: (2013)

Mild Moxibustion Decreases the Expression of Prokineticin 2 and Prokineticin Receptor 2 in the Colon and Spinal Cord of Rats with Irritable Bowel Syndrome
by: Zhou, Cili, et al.
Published: (2014)

PDIA3 gene induces visceral hypersensitivity in rats with irritable bowel syndrome through the dendritic cell-mediated activation of T cells
by: Zhuang, Zhaomeng, et al.
Published: (2016)

What Is the Therapeutic Mechanism of the Probiotics in Irritable Bowel Syndrome Patients With Visceral Hypersensitivity?: (Neurogastroenterol Motil 2014;26:705–714)
by: Kim, Ji Won
Published: (2014)

Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom
by: Layer, Peter, et al.
Published: (2007)

Linaclotide: evidence for its potential use in irritable bowel syndrome and chronic constipation
by: Lee, Noel, et al.
Published: (2012)

Lubiprostone for the Treatment of Adult Women with Irritable Bowel Syndrome with Constipation
by: Soubra, Mahmoud, et al.
Published: (2012)

The effect of biofeedback therapy on dyssynergic constipation in patients with or without Irritable Bowel Syndrome
by: Ahadi, Tannaz, et al.
Published: (2014)

Review article: linaclotide for the management of irritable bowel syndrome with constipation
by: Layer, P, et al.
Published: (2014)

Colonic response to laxative ingestion as assessed by MRI differs in constipated irritable bowel syndrome compared to functional constipation
by: Lam, C., et al.
Published: (2016)

Linaclotide: A New Option for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation in Adults
by: Parker, Colleen H., et al.
Published: (2013)

Colonic response to laxative ingestion as assessed by MRI differs in constipated irritable bowel syndrome compared to functional constipation
by: Lam, C., et al.
Published: (2016)